231 related articles for article (PubMed ID: 10802359)
1. Urinary morbidity with a modified peripheral loading technique of transperineal (125)i prostate implantation.
Brown D; Colonias A; Miller R; Benoit R; Cohen J; Arshoun Y; Galloway M; Karlovits S; Wu A; Johnson M; Quinn A; Kalnicki S
Int J Radiat Oncol Biol Phys; 2000 May; 47(2):353-60. PubMed ID: 10802359
[TBL] [Abstract][Full Text] [Related]
2. Urinary morbidity following ultrasound-guided transperineal prostate seed implantation.
Gelblum DY; Potters L; Ashley R; Waldbaum R; Wang XH; Leibel S
Int J Radiat Oncol Biol Phys; 1999 Aug; 45(1):59-67. PubMed ID: 10477007
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the 5-year outcome and morbidity of three-dimensional conformal radiotherapy versus transperineal permanent iodine-125 implantation for early-stage prostatic cancer.
Zelefsky MJ; Wallner KE; Ling CC; Raben A; Hollister T; Wolfe T; Grann A; Gaudin P; Fuks Z; Leibel SA
J Clin Oncol; 1999 Feb; 17(2):517-22. PubMed ID: 10080594
[TBL] [Abstract][Full Text] [Related]
4. Five-year biochemical outcome and toxicity with transperineal CT-planned permanent I-125 prostate implantation for patients with localized prostate cancer.
Zelefsky MJ; Hollister T; Raben A; Matthews S; Wallner KE
Int J Radiat Oncol Biol Phys; 2000 Jul; 47(5):1261-6. PubMed ID: 10889379
[TBL] [Abstract][Full Text] [Related]
5. I-125 versus Pd-103 for low-risk prostate cancer: morbidity outcomes from a prospective randomized multicenter trial.
Wallner K; Merrick G; True L; Cavanagh W; Simpson C; Butler W
Cancer J; 2002; 8(1):67-73. PubMed ID: 11895205
[TBL] [Abstract][Full Text] [Related]
6. Acute genitourinary toxicity after high-dose-rate (HDR) brachytherapy combined with hypofractionated external-beam radiation therapy for localized prostate cancer: correlation between the urethral dose in HDR brachytherapy and the severity of acute genitourinary toxicity.
Akimoto T; Ito K; Saitoh J; Noda SE; Harashima K; Sakurai H; Nakayama Y; Yamamoto T; Suzuki K; Nakano T; Niibe H
Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):463-71. PubMed ID: 16168838
[TBL] [Abstract][Full Text] [Related]
7. Prostate seed implantation using 3D-computer assisted intraoperative planning vs. a standard look-up nomogram: Improved target conformality with reduction in urethral and rectal wall dose.
Raben A; Chen H; Grebler A; Geltzeiler J; Geltzeiler M; Keselman I; Litvin S; Sim S; Hanlon A; Yang J
Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1631-8. PubMed ID: 15590195
[TBL] [Abstract][Full Text] [Related]
8. Factors predicting for urinary incontinence after prostate brachytherapy.
McElveen TL; Waterman FM; Kim H; Dicker AP
Int J Radiat Oncol Biol Phys; 2004 Aug; 59(5):1395-404. PubMed ID: 15275725
[TBL] [Abstract][Full Text] [Related]
9. Improved conformality and decreased toxicity with intraoperative computer-optimized transperineal ultrasound-guided prostate brachytherapy.
Zelefsky MJ; Yamada Y; Marion C; Sim S; Cohen G; Ben-Porat L; Silvern D; Zaider M
Int J Radiat Oncol Biol Phys; 2003 Mar; 55(4):956-63. PubMed ID: 12605973
[TBL] [Abstract][Full Text] [Related]
10. Acute urinary toxicity following transperineal prostate brachytherapy using a modified Quimby loading method.
Kang SK; Chou RH; Dodge RK; Clough RW; Kang HL; Bowen MG; Steffey BA; Das SK; Zhou SM; Whitehurst AW; Buckley NJ; Kim JH; Joyner RE; Sarmina I; Montana GS; Ingram SS; Anscher MS
Int J Radiat Oncol Biol Phys; 2001 Jul; 50(4):937-45. PubMed ID: 11429221
[TBL] [Abstract][Full Text] [Related]
11. Dosimetry guidelines to minimize urethral and rectal morbidity following transperineal I-125 prostate brachytherapy.
Wallner K; Roy J; Harrison L
Int J Radiat Oncol Biol Phys; 1995 May; 32(2):465-71. PubMed ID: 7751187
[TBL] [Abstract][Full Text] [Related]
12. Predictive factors of acute urinary morbidity after iodine-125 brachytherapy for localised prostate cancer: a phase 2 study.
Salem N; Simonian-Sauve M; Rosello R; Alzieu C; Gravis G; Maraninchi D; Bladou F
Radiother Oncol; 2003 Feb; 66(2):159-65. PubMed ID: 12648787
[TBL] [Abstract][Full Text] [Related]
13. Relationship between percent positive biopsies and biochemical outcome after permanent interstitial brachytherapy for clinically organ-confined carcinoma of the prostate gland.
Merrick GS; Butler WM; Galbreath RW; Lief JH; Adamovich E
Int J Radiat Oncol Biol Phys; 2002 Mar; 52(3):664-73. PubMed ID: 11849788
[TBL] [Abstract][Full Text] [Related]
14. Clinical correlates of high intraprostatic brachytherapy dose volumes.
Jones S; Wallner K; Merrick G; Corriveau J; Sutlief S; True L; Butler W
Int J Radiat Oncol Biol Phys; 2002 Jun; 53(2):328-33. PubMed ID: 12023136
[TBL] [Abstract][Full Text] [Related]
15. Temporal resolution of urinary morbidity following prostate brachytherapy.
Merrick GS; Butler WM; Lief JH; Dorsey AT
Int J Radiat Oncol Biol Phys; 2000 Apr; 47(1):121-8. PubMed ID: 10758313
[TBL] [Abstract][Full Text] [Related]
16. Morbidity effect of the time gap between supplemental beam radiation and Pd-103 prostate brachytherapy.
Corriveau J; Wallner K; Merrick G; True L; Cavanagh W; Sutlief S; Butler W
Brachytherapy; 2003; 2(2):108-13. PubMed ID: 15062149
[TBL] [Abstract][Full Text] [Related]
17. Acute genitourinary toxicity after high dose rate (HDR) brachytherapy combined with hypofractionated external-beam radiation therapy for localized prostate cancer: Second analysis to determine the correlation between the urethral dose in HDR brachytherapy and the severity of acute genitourinary toxicity.
Akimoto T; Katoh H; Noda SE; Ito K; Yamamoto T; Kashiwagi B; Nakano T
Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):472-8. PubMed ID: 16168839
[TBL] [Abstract][Full Text] [Related]
18. Long-term urinary function after transperineal brachytherapy for patients with large prostate glands.
Sherertz T; Wallner K; Wang H; Sutlief S; Russell K
Int J Radiat Oncol Biol Phys; 2001 Dec; 51(5):1241-5. PubMed ID: 11728683
[TBL] [Abstract][Full Text] [Related]
19. Identifying the predictors of acute urinary retention following magnetic-resonance-guided prostate brachytherapy.
Thomas MD; Cormack R; Tempany CM; Kumar S; Manola J; Schneider L; Hurwitz MD; D'Amico AV
Int J Radiat Oncol Biol Phys; 2000 Jul; 47(4):905-8. PubMed ID: 10863058
[TBL] [Abstract][Full Text] [Related]
20. Transperineal ultrasound-guided radioactive seed implantation for organ-confined carcinoma of the prostate.
Stokes SH; Real JD; Adams PW; Clements JC; Wuertzer S; Kan W
Int J Radiat Oncol Biol Phys; 1997 Jan; 37(2):337-41. PubMed ID: 9069305
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
